BPA Call HT001421A0031-HT001423F0136
Award Date 9/8/23
Potential Completion Date 9/7/24
Potential Value $145K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded Genomic Health, Inc. a $145,066.32 firm fixed-price BPA call for Oncotype IQ genomic testing services, with an ultimate completion date of September 7, 2026. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in advanced genetic testing services focused on oncology diagnostics, particularly the Oncotype DX portfolio of gene expression assays. These tests support cancer screening, treatment selection, and disease monitoring across breast,...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of diagnostic testing supplies for cancer treatment. The potential value of the contract is $150,000.00, with a completion date of September 7, 2022. The contract was not set aside for any specific business type. Genomic Health has a history of providing cancer testing services, including its Oncotype DX portfolio of...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for the provision of "Oncotype Testing" services to support cancer diagnoses at the Fort Belvoir Community Hospital's Anatomic Pathology Department. The contract has a potential value of $250,000.00 and a period of performance running from the award date of October 17, 2020 through October 16, 2021. No set-aside designation was...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide laboratory testing services. The contract has a potential value of $165,621.24 and a period of performance through September 30, 2020. Genomic Health has previously provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under over 30...
- This is a federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of the Oncotype portfolio of genomic tests to support patient care in anatomic pathology. The contract has a ceiling value of $145,066.32 and was awarded by the Defense Health Agency, a defense agency, on September 8, 2024. The contract type is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure, and an ultimate completion date of September 7,...
- This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
- This federal contract award is for Oncotype DX breast cancer testing services provided by Genomic Health, Inc. to the Defense Health Agency. The $13,815.84 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call, with a performance period ending on May 31, 2018. Genomic Health, a subsidiary of Exact Sciences Corporation, is a for-profit organization that specializes in providing advanced genetic testing services to federal healthcare systems. The company has several large Indefinite...
- This is a delivery order awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of Oncotype cancer testing services to the Defense Health Agency (DHA). The contract has a ceiling value of $124,588.79 and a period of performance from March 16, 2025, to March 15, 2026, with the testing to be performed at Nellis Air Force Base in Nevada. The contract is a firm fixed-price type and does not have a set-aside designation. Genomic Health, Inc. is a for-profit...
- This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX breast cancer testing services. The contract has an ultimate completion date of February 8, 2018 and a ceiling value of $10,361.88. Genomic Health, Inc. is a for-profit organization that specializes in advanced genetic testing services for federal healthcare systems. The company has been awarded several...